v3.26.3
Related Party Transactions (Details) - USD ($)
3 Months Ended
May 26, 2026
Mar. 31, 2026
Nov. 13, 2023
Nov. 01, 2019
Sep. 30, 2026
Sep. 30, 2025
Jun. 30, 2026
Sep. 23, 2024
Related Party Transactions                
Prepaid expenses         $ 405,047   $ 368,513  
Research and Development Costs - Related Party         4,697,186 $ 993,066    
Related party                
Related Party Transactions                
Accounts Payable - Related Party         704,441   828,577  
Dr. Anil R Diwan | Minimum                
Related Party Transactions                
Line of credit               $ 2,000,000
Maturity of the Company's line of Credit   Mar. 31, 2027            
Dr. Anil R Diwan | Maximum                
Related Party Transactions                
Line of credit               $ 3,000,000
Maturity of the Company's line of Credit   Dec. 31, 2027            
Line of credit agreement | Dr. Anil R Diwan                
Related Party Transactions                
Line of Credit Facility, maximum borrowing capacity     $ 2,000,000          
Fixed rate of interest on the amount drawn under the line of credit facility     12.00%          
Drew down amount         0      
TheraCour Pharma Inc                
Related Party Transactions                
Accounts payable offset by advance         0   0  
TheraCour Pharma Inc | Related party                
Related Party Transactions                
Accounts Payable - Related Party         704,441   828,577  
Percentage of direct costs       30.00%        
Other general and administrative expense       $ 2,000        
Percentage of net sales allocated for royalty payments (in percent)       15.00%        
Accrued royalties         0 0    
Research and Development Costs - Related Party         549,606 $ 539,522    
KMPL | Related party                
Related Party Transactions                
Clinical trial Costs Accrued - Related Party         1,199,395   $ 43,610  
Payment of clinical trial costs $ 299,130              
Prepaid expenses         255,520      
Clinical trial costs charged against prepaid funds         0      
KMPL | MPox Phase II clinical trial                
Related Party Transactions                
Clinical trial costs expenses - Related party         226,415      
Clinical trial costs fees - Related party         306,015      
KMPL | Ebola Phase II clinical trial                
Related Party Transactions                
Clinical trial costs expenses - Related party         279,402      
Clinical trial costs fees - Related party         $ 387,563